Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors

Human Pathology

Volumn 40, Issue 9, 2009, Pages 1262-1268

  Strosberg, Jonathan ^a   Nasir, Aejaz ^a   Coppola, Domenico ^a   Wick, Mark ^b   Kvols, Larry ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

Author keywords

Carcinoid tumors; Differentiation; Grade; Islet cell tumors; Neuroendocrine tumors; Pancreatic endocrine tumors; Prognosis

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CORRELATION ANALYSIS; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MITOSIS RATE; NEUROENDOCRINE TUMOR; OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; KI-67 ANTIGEN; MALE; MIDDLE AGED; MITOSIS; NEOPLASM METASTASIS; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 68349157118     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.01.010     Document Type: Article

References (28)

1. Arrigoni M.G., Woolner L.B., and Bernatz P.E. Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 64 (1972) 413-421
2. Travis W.D., Rush W., Flieder D.B., et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 22 (1998) 934-944
3. Rosai J., Levine G., Weber W.R., and Higa E. Carcinoid tumors and oat cell carcinomas of the thymus. Pathol Annu. 11 (1976) 201-226
4. Moran C.A., and Suster S. Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases. Am J Clin Pathol 114 (2000) 100-110
5. Costes V., Marty-Ane C., Picot M.C., et al. Typical and atypical bronchopulmonary carcinoid tumors: a clinicopathologic and KI-67-labeling study. Hum Pathol 26 (1995) 740-745
6. Bohm J., Koch S., Gais P., Jutting U., Prauer H.W., and Hofler H. Prognostic value of MIB-1 in neuroendocrine tumours of the lung. J Pathol 178 (1996) 402-409
7. von Herbay A., Sieg B., Schurmann G., Hofmann W.J., Betzler M., and Otto H.F. Proliferative activity of neuroendocrine tumours of the gastroenteropancreatic endocrine system: DNA flow cytometric and immunohistological investigations. Gut 32 (1991) 949-953
8. Moyana T.N., Xiang J., Senthilselvan A., and Kulaga A. The spectrum of neuroendocrine differentiation among gastrointestinal carcinoids: importance of histologic grading, MIB-1, p53, and bcl-2 immunoreactivity. Arch Pathol Lab Med 124 (2000) 570-576
9. Rindi G., Azzoni C., La Rosa S., et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 116 (1999) 532-542
10. La Rosa S., Sessa F., Capella C., et al. Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch 429 (1996) 323-333
11. Zimmermann M.E., and Bosman F.T. Proliferative activity of well differentiated neuroendocrine tumours of the gut. Histol Histopathol 18 (2003) 353-358
12. Al-Khafaji B., Noffsinger A.E., Miller M.A., DeVoe G., Stemmermann G.N., and Fenoglio-Preiser C. Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumors. Hum Pathol 29 (1998) 992-999
13. Hochwald S.N., Zee S., Conlon K.C., et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol 20 (2002) 2633-2642
14. Capella C., Heitz P.U., Hofler H., Solcia E., and Kloppel G. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch. 425 (1995) 547-560
15. Kloppel G., Heitz P.U., Capella C., and Solcia E. Pathology and nomenclature of human gastrointestinal neuroendocrine (carcinoid) tumors and related lesions. World J Surg 20 (Feb 1996) 132-141
16. Kloppel G., Perren A., and Heitz P.U. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 1014 (2004) 13-27
17. In: DeLellis R.A., Lloyd R.V., Heitz P.U., and Eng C. (Eds). World Health Organization classification of tumours, pathology, and genetics of tumours of endocrine organs (2004), IARCPress, Lyon
18. Kloppel G., Solcia E., Capella C., and Heitz P.U. Classification of neuroendocrine tumours. Ital J Gastroenterol Hepatol 31 Suppl 2 (1999) S111-S116
19. Rindi G., and Kloppel G. Endocrine tumors of the gut and pancreas tumor biology and classification. Neuroendocrinology 80 Suppl 1 (2004) 12-15
20. Wick M.R., and Graeme-Cook F.M. Pancreatic neuroendocrine neoplasms: a current summary of diagnostic, prognostic, and differential diagnostic information. Am J Clin Pathol 115 Suppl (2001) S28-S45
21. Wick M.R. Neuroendocrine neoplasia. Current concepts. Am J Clin Pathol 113 (2000) 331-335
22. Van Eeden S., Quaedvlieg P.F., Taal B.G., Offerhaus G.J., Lamers C.B., and Van Velthuysen M.L. Classification of low-grade neuroendocrine tumors of midgut and unknown origin. Hum Pathol 33 (2002) 1126-1132
23. Tomassetti P., Campana D., Piscitelli L., et al. Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol 16 (2005) 1806-1810
24. Panzuto F., Nasoni S., Falconi M., et al. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer 12 (2005) 1083-1092
25. Rorstad O. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract. J Surg Oncol 89 (2005) 151-160
26. Furlan D., Cerutti R., Uccella S., et al. Different molecular profiles characterize well-differentiated endocrine tumors and poorly differentiated endocrine carcinomas of the gastroenteropancreatic tract. Clin Cancer Res 10 (2004) 947-957
27. Rindi G., Kloppel G., Alhman H., et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449 (2006) 395-401
28. Rindi G., Kloppel G., Couvelard A., et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 451 (2007) 757-762